CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,826 | -45.1% | 16,424 | -8.8% | 0.00% | – |
| Q2 2023 | $10,609 | -15.3% | 18,009 | -18.0% | 0.00% | – |
| Q1 2023 | $12,528 | -21.9% | 21,960 | -8.7% | 0.00% | – |
| Q4 2022 | $16,048 | -83.6% | 24,060 | -64.3% | 0.00% | – |
| Q3 2022 | $98,000 | -38.4% | 67,340 | +122.8% | 0.00% | – |
| Q3 2021 | $159,000 | -43.0% | 30,221 | -35.8% | 0.00% | -100.0% |
| Q2 2021 | $279,000 | +206.6% | 47,070 | +266.2% | 0.00% | – |
| Q1 2021 | $91,000 | – | 12,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |